The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Anxiety in Parkinson's disease: identification and management
Open accessAbstract
Anxiety disturbances are recognized as common psychiatric comorbidities in Parkinson’s disease (PD) and contribute to significant impairments in areas of cognitive, functional, motor and social performance. Anxiety in PD results in reduced quality of life, higher levels of care dependency and increased caregiver burden. Surprisingly, there is a paucity of treatment data. In one randomized, controlled study, bromazepam was found to be effective for anxiety in PD. However, usage of benzodiazepines in the PD population is limited by potential risk of confusion and falls. There are no controlled studies of selective serotonin reuptake inhibitors (SSRIs) for anxiety in PD. However, results from uncontrolled studies suggest that SSRIs are effective for anxiety in PD, although in these studies anxiety outcomes were secondary. This review underscores that, given the high prevalence of anxiety disturbances in PD, there is a significant paucity of treatment data for this population. Additional studies are warranted. In the meantime, clinicians should rely on empiric assessments of known risks and putative benefits to guide treatment decisions. Cognitive and behavioral therapies (with or without pharmacotherapy) have demonstrated efficacy and warrant consideration. When feasible, a targeted and individualized multimodal approach utilizing psychotherapeutic interventions along with pharmacologic therapies should be considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“concerns regarding unfavorable side effects, including exacerbation of motor problems in patients with complex medication regimes, have been noted (Rabinstein and Shulman, 2000”
From Remote delivery of psychological interventions for Parkinson's disease. (2018) · cites this paper as Chen and Marsh, 2014
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Diagnostic and Statistical Manual of Mental Disorders.
Widiger, T. A. (2000) · Oxford University Press eBooks · doi:10.1037/10518-009 · Cited by 19,766
An inventory for measuring clinical anxiety: Psychometric properties.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.56.6.893 · Cited by 14,407
Parkinson, J. (2002) · Journal of Neuropsychiatry · doi:10.1176/jnp.14.2.223 · Cited by 2,856
Rémy, P., Doder, M., Lees, A. J., Turjanski, N., & Brooks, D. J. (2005) · Brain · doi:10.1093/brain/awh445 · Cited by 1,090
Drug Facts and Comparisons 1991.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-823_1 · Cited by 776
Non-recognition of depression and other non-motor symptoms in Parkinson's disease
Shulman, L. M., Taback, R. L., Rabinstein, A. A., & Weiner, W. J. (2002) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(01)00015-3 · Cited by 695
Nonmotor fluctuations in Parkinson’s disease: Frequent and disabling
Witjas, T., Kaphan, E., Azulay, J. P., Blin, O., Ceccaldi, M., Pouget, J., Poncet, M., & Chérif, A. A. (2002) · Neurology · doi:10.1212/wnl.59.3.408 · Cited by 642
Factors impacting on quality of life in Parkinson's disease: Results from an international survey
The Global Parkinson's Disease Survey (GPDS) Steering Committee (2002) · Movement Disorders · doi:10.1002/mds.10010 · Cited by 524
Gallagher, D. A., Lees, A. J., & Schrag, A. E. (2010) · Movement Disorders · doi:10.1002/mds.23394 · Cited by 506
Anxiety disorders in Parkinson's disease: Prevalence and risk factors
Dissanayaka, N. N., Sellbach, A. N., Matheson, S., O’Sullivan, J. D., Silburn, P. A., Byrne, G. J., Marsh, R., & Mellick, G. D. (2010) · Movement Disorders · doi:10.1002/mds.22833 · Cited by 408
Effect of Psychiatric and Other Nonmotor Symptoms on Disability in Parkinson's Disease
Weintraub, D., Moberg, P. J., Duda, J. E., Katz, I. R., & Stern, M. B. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52219.x · Cited by 381
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
Richard, I., McDermott, M. P., Kurlan, R., Lyness, J. M., Como, P. G., Pearson, N., Factor, S. A., Juncos, J. L., Ramos, C. S., Brodsky, M., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182516244 · Cited by 335
Self-citationBenzodiazepines and Risk of Hip Fractures in Older People
Cumming, R. G., & Couteur, D. G. L. (2003) · CNS Drugs · doi:10.2165/00023210-200317110-00004 · Cited by 332
Routinely administered questionnaires for depression and anxiety: systematic review
Gilbody, S. M., House, A. O., & Sheldon, T. (2001) · BMJ · doi:10.1136/bmj.322.7283.406 · Cited by 328
Marsh, L., McDonald, W. M., Cummings, J. L., Ravina, B. M., & NINDS/NIMH Work Group on Depression and Parkinson's Disease (2005) · Movement Disorders · doi:10.1002/mds.20723 · Cited by 319
Self-citationParkinson's disease and anxiety: Comorbidity with depression
Menza, M. A., Robertson-Hoffman, D. E., & Bonapace, A. S. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90237-8 · Cited by 316
Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression
Mace, S., & Taylor, D. M. (2000) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.1.5.917 · Cited by 315
Cognitive-Behavioral Therapy for Depression in Parkinson's Disease: A Randomized, Controlled Trial
Dobkin, R. D., Menza, M., Allen, L. A., Gara, M. A., Mark, M. H., Tiu, J., Bienfait, K. L., & Friedman, J. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10111669 · Cited by 310
Anxiety disorders in patients with Parkinson's disease
Stein, M. B., Heuser, I. J. E., Juncos, J. L., & Uhde, T. W. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.2.217 · Cited by 289
Leentjens, A. F. G., Dujardin, K., Marsh, L., Richard, I. H., STARKSTEIN, S. E., & Martínez‐Martín, P. (2011) · Movement Disorders · doi:10.1002/mds.23184 · Cited by 233
Self-citationSerotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease
Richard, I., Kurlan, R., Tanner, C. M., Factor, S. A., Hubble, J. P., Suchowersky, O., Waters, C., & the Parkinson Study Group (1997) · Neurology · doi:10.1212/wnl.48.4.1070 · Cited by 230
Recognition and Treatment of Depression in Parkinson's Disease
Weintraub, D. A., Moberg, P. J., Duda, J. E., Katz, I. R., & Stern, M. B. (2003) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988703256053 · Cited by 209
Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria.
(2000) · PubMed Central · Cited by 207
Psychiatric comorbidity in a population of Parkinson's disease patients
Nuti, A., Ceravolo, R., Piccinni, A., Dell’Agnello, G., Bellini, G., Gambaccini, G., Rossi, C. A., Logi, C., Dell’Osso, L., & Bonuccelli, U. (2004) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00781.x · Cited by 205
Anxiety and Parkinson's disease
Richard, I., Schiffer, R. B., & Kurlan, R. (1996) · Journal of Neuropsychiatry · doi:10.1176/jnp.8.4.383 · Cited by 201
Evaluation of the Hospital Anxiety and Depression Scale in Patients With Parkinson's Disease
Marinus, J., Leentjens, A. F. G., Visser, M., Stiggelbout, A. M., & van Hilten, J. J. (2002) · Clinical Neuropharmacology · doi:10.1097/00002826-200211000-00008 · Cited by 197
Anxiety in Parkinson’s disease: A critical review of experimental and clinical studies
Prediger, R. D. S., Matheus, F. C., Schwarzbold, M. L., Lima, M. M. S., & Vital, M. A. B. F. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.039 · Cited by 190
Positron Emission Tomography of Striatal Serotonin Transporters in Parkinson Disease
Kerényi, L., Ricaurte, G. A., Schretlen, D. J., McCann, U. D., Varga, J., Mathews, W. B., Ravert, H. T., Dannals, R. F., Hilton, J., Wong, D. F., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.9.1223 · Cited by 154
Prospective study of phobic anxiety and risk of Parkinson's disease
Weisskopf, M. G., Chen, H., Schwarzschild, M. A., Kawachi, I. I., & Ascherio, A. (2003) · Movement Disorders · doi:10.1002/mds.10425 · Cited by 151
"Panic attacks" in Parkinson's disease. A long-term complication of levodopa therapy.
Vázquez, A., Jiménez-Jiménez, F. J., Ruiz, P., & García-Urra, D. (1993) · PubMed · Cited by 142
Effectiveness of ECT in Patients With Parkinsonism
Moellentine, C. K., Rummans, T. A., Ahlskog, J. E., Harmsen, W. S., Suman, V. J., O'Connor, M. K., Black, J. L., & Pileggi, T. S. (1998) · Journal of Neuropsychiatry · doi:10.1176/jnp.10.2.187 · Cited by 139
Mood swings associated with the ‘on—off’ phenomenon in Parkinson's disease
Nissenbaum, H., Quinn, N. P., Brown, R. G., Toone, B., Gotham, A.-M., & MARSDEN, C. D. (1987) · Psychological Medicine · doi:10.1017/s0033291700000702 · Cited by 139
“Panic attacks” in Parkinson's disease
Vázquez, A., Jiménez-Jiménez, F. J., Ruiz, P., & García-Urra, D. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1993.tb04068.x · Cited by 128
Evidence for atypical depression in Parkinson's disease
Schiffer, R. B., Kurlan, R., Rubin, A., & Boer, S. (1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.8.1020 · Cited by 127
SSRIs Do Not Worsen Parkinson's Disease: Evidence from an Open-Label, Prospective Study
Dell’Agnello, G., Ceravolo, R., Nuti, A., Bellini, G., Piccinni, A., D’Avino, C., Dell’Osso, L., & Bonuccelli, U. (2001) · Clinical Neuropharmacology · doi:10.1097/00002826-200107000-00005 · Cited by 119
Neurobiology of Depression and Anxiety in Parkinson's Disease
Kano, O., Ikeda, K., Cridebring, D., Takazawa, T., Yoshii, Y., & Iwasaki, Y. (2011) · Parkinson s Disease · doi:10.4061/2011/143547 · Cited by 107
Psychometric attributes of the Hospital Anxiety and Depression Scale in Parkinson's disease
Rodriguez‐Blazquez, C., Frades‐Payo, B., Forjaz, M. J., de Pedro‐Cuesta, J., Martinez‐Martin, P., & on behalf of the Longitudinal Parkinson's Disease Patient Study (Estudio longitudinal de pacientes con enfermedad de Parkinson ‐ELEP) Group (2009) · Movement Disorders · doi:10.1002/mds.22321 · Cited by 97
Impact of Anxiety on Quality of Life in Parkinson's Disease
Hanna, K. K., & Cronin‐Golomb, A. (2011) · Parkinson s Disease · doi:10.1155/2012/640707 · Cited by 95
Correlates of Generalized Anxiety and Panic Attacks in Dystonia and Parkinson Disease
Lauterbach, E. C., Freeman, A., & Vogel, R. L. (2003) · Cognitive and Behavioral Neurology · doi:10.1097/00146965-200312000-00004 · Cited by 82
(2004) · PubMed · Cited by 82
Psychosocial Interventions for Depression and Anxiety in Parkinson's Disease
Nagle-Yang, S. M., Sajatovic, M., & Walter, B. L. (2012) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988712445096 · Cited by 80
Menza, M. A., Marín, H., Kaufman, K. R., Mark, M. H., & Lauritano, M. (2004) · Journal of Neuropsychiatry · doi:10.1176/jnp.16.3.315 · Cited by 76
Anxiety and self-perceived health status in Parkinson’s disease
Pontone, G. M., Williams, J. R., Anderson, K. E., Chase, G. A., Goldstein, S. R., Grill, S. E., Hirsch, E. S., Lehmann, S. W., Little, J. T., Margolis, R. L., et al. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.01.005 · Cited by 72
Self-citationEvaluation of anxiety in Parkinson’s disease with some commonly used rating scales
Mondolo, F., Jahanshahi, M., Granà, A., Biasutti, E., Cacciatori, E., & Benedetto, P. D. (2007) · Neurological Sciences · doi:10.1007/s10072-007-0834-9 · Cited by 72
Cognitive and Motor Function in Patients with Parkinson's Disease with and without Depression
Cubo, E., Bernard, B., Leurgans, S. E., & Raman, R. (2000) · Clinical Neuropharmacology · doi:10.1097/00002826-200011000-00006 · Cited by 70
Buspirone, Parkinsonʼs Disease, and the Locus Ceruleus
Ludwig, C. L., Weinberger, D. R., Bruno, G., Gillespie, M., Bakker, K., LeWitt, P. A., & Chase, T. N. (1986) · Clinical Neuropharmacology · doi:10.1097/00002826-198608000-00004 · Cited by 64
Clinical Features and Comorbidity of Mood Fluctuations in Parkinson's Disease
Racette, B. A., Hartlein, J. M., Hershey, T. G., Mink, J. W., Perlmutter, J. S., & BLACK, K. J. (2002) · Journal of Neuropsychiatry · doi:10.1176/jnp.14.4.438 · Cited by 63
Gony, M., Lapeyre‐Mestre, M., & Montastruc, J. (2003) · Clinical Neuropharmacology · doi:10.1097/00002826-200305000-00007 · Cited by 62
Validity and reliability of the Geriatric Anxiety Inventory in Parkinson's disease*†
Matheson, S., Byrne, G. J., Dissanayaka, N. N., Pachana, N. A., Mellick, G. D., O’Sullivan, J. D., Silburn, P. A., Sellbach, A. N., & Marsh, R. (2010) · Australian Journal on Ageing · doi:10.1111/j.1741-6612.2010.00487.x · Cited by 58
Internal tremor in patients with Parkinson's disease
Shulman, L. M., Singer, C., Bean, J. A., & Weiner, W. J. (1996) · Movement Disorders · doi:10.1002/mds.870110103 · Cited by 56
Somatization and Health Anxiety as Predictors of Health Care Use
Tomenson, B., McBeth, J., Chew-Graham, C. A., MacFarlane, G., Davies, I., Jackson, J., Littlewood, A., & Creed, F. H. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31825cb140 · Cited by 51
Cognitive Behavioral Therapy for Depression and Anxiety in Parkinson's Disease: A Clinical Review
Armento, M. E. A., Stanley, M. A., Marsh, L., Kunik, M. E., York, M. K., Bush, A. L., & Calleo, J. S. (2012) · Journal of Parkinson's Disease · doi:10.3233/jpd-2012-12080 · Cited by 49
Self-citationvan de Vijver, D. A. M. C., Roos, R. A. C., Jansen, P. A. F., Porsius, A. J., & de Boer, A. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2001.01491.x · Cited by 48
Psychiatric symptoms in Parkinson’s disease assessed with the SCL-90R self-reported questionnaire
Siri, C., Cilia, R., Gaspari, D. D., Villa, F., Goldwurm, S., Catalano, M., Pezzoli, G., & Antonini, A. (2009) · Neurological Sciences · doi:10.1007/s10072-009-0165-0 · Cited by 45
Rasch analysis of the hospital anxiety and depression scale in Parkinson's disease
Forjaz, M. J., Rodríguez‐Blázquez, C., Martínez‐Martín, P., & on behalf of the Longitudinal Parkinson's Disease Patient Study (Estudio Longitudinal de Pacientes con Enfermedad de Parkinson—ELEP) Group (2008) · Movement Disorders · doi:10.1002/mds.22409 · Cited by 43
Social Anxiety in Patients With Parkinson's Disease
Bolluk, B., Ozel-Kizil, E. T., Akbostancı, M. C., & Atbasoglu, E. C. (2010) · Journal of Neuropsychiatry · doi:10.1176/jnp.2010.22.4.390 · Cited by 40
Asymmetry of basal ganglia glucose metabolism and dopa responsiveness in parkinsonism
Dethy, S., Blercom, N. V., Damhaut, P., Wikler, D., Hildebrand, J. G., & Goldman, S. (1998) · Movement Disorders · doi:10.1002/mds.870130213 · Cited by 37
Neurobehavioral Functioning of Persons With Parkinson's Disease
Mathias, J. L. (2003) · Applied Neuropsychology · doi:10.1207/s15324826an1002_01 · Cited by 36
Anxiety and Depression in Parkinson’s Disease
STARKSTEIN, S. E., Robinson, R. G., Leiguarda, R., & Preziosi, T. J. (1993) · Behavioural Neurology · doi:10.1155/1993/539179 · Cited by 35
Parkinson's Disease, Depression, and the On-Off Phenomenon
Friedenberg, D. L., & Cummings, J. L. (1989) · Psychosomatics · doi:10.1016/s0033-3182(89)72323-9 · Cited by 32
Anxiety and depression in Parkinson's disease.
STARKSTEIN, S. E., Robinson, R. G., Leiguarda, R. C., & Preziosi, T. J. (1993) · PubMed · doi:10.3233/ben-1993-6306 · Cited by 29
Riedel, O., Dodel, R. C., Deuschl, G., Klotsche, J., Förstl, H., Heuser, I., Oertel, W. H., Reichmann, H., Riederer, P. F., Trenkwalder, C., et al. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.11.007 · Cited by 27
Pharmacologic Safety Concerns in Parkinson's Disease: Facts and Insights
Chen, J. J. (2011) · International Journal of Neuroscience · doi:10.3109/00207454.2011.620193 · Cited by 22
Self-citationAN ESSAY ON THE SHAKING PALSY, BY JAMES PARKINSON, M.D., MEMBER OF THE ROYAL COLLEGE OF SURGEONS
Ostheimer, A. J. (1922) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1922.02190120002001 · Cited by 20
Marino, L. J., & Friedman, J. H. (2012) · International Journal of Neuroscience · doi:10.3109/00207454.2012.726300 · Cited by 19
[Treatment of anxiety in Parkinson's disease with bromazepam].
CASACCHIA, M., Zamponi, A. F., Squitieri, G., & Meco, G. (1975) · PubMed · Cited by 16
Chuang, C., Kocen, R. S., Quinn, N. P., & Daniel, S. E. (2001) · Movement Disorders · doi:10.1002/mds.1065 · Cited by 9
Correlation of Parkinson's disease severity and duration with123I-FP-CIT SPECT striatal uptake
Benamer, H. T. S., Patterson, J., Wyper, D. J., Hadley, D. M., Macphee, G. J. A., & Grosset, D. G. (2000) · Movement Disorders · doi:10.1002/1531-8257(200007)15:4
Research works printed but not linked: 6
- Black K., 2000, J Psychiatry Neurosci, 25, 255
- Casacchia M., 1975, Riv Neurol, 45, 326
- Hanna K., 2012, Parkinsons Dis, 2012, 640707
- Kano O., 2011, Parkinsons Dis, 2011, 143547
- Richard I., 2004, Cogn Behav Neurol, 17, 201
- Shulman L., 1996, Mov Disord, 11, 12
Cited by
Sorted by citations
Maiti, P., Manna, J., & Dunbar, G. L. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0099-z · Cited by 557
van Uem, J. M. T., Marinus, J., Canning, C. G., van Lummel, R. C., Dodel, R. C., Liepelt‐Scarfone, I., Berg, D., Morris, M. E., & Maetzler, W. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.11.014 · Cited by 218
Reynolds, G., Otto, M. W., Ellis, T. D., & Cronin‐Golomb, A. (2015) · Movement Disorders · doi:10.1002/mds.26484 · Cited by 144
The clinical spectrum of anxiety in Parkinson's disease
Dissanayaka, N. N. N. W., White, E., O'Sullivan, J. D., Marsh, R., Pachana, N. A., & Byrne, G. J. (2014) · Movement Disorders · doi:10.1002/mds.25937 · Cited by 124
Psychiatric Manifestation in Patients with Parkinson's Disease
Han, J. W., Ahn, Y. D., Kim, W.-S., Shin, C. M., Jeong, S. J., Song, Y. S., Bae, Y. J., & Kim, J.-M. (2018) · Journal of Korean Medical Science · doi:10.3346/jkms.2018.33.e300 · Cited by 127
Metadata
- Authors
- Chen, J. J., & Marsh, L.
- Affiliations
- Loma Linda University (US)
- Michael E. DeBakey VA Medical Center (US)
- Venue
- Therapeutic Advances in Neurological Disorders
- Publisher
- SAGE Publications
- Published
- 2013-07-17
- Volume
- 7
- Issue
- 1
- Pages
- 52-59
- ISSN
- 1756-2856 (ISSN-L)
- 1756-2864
- PMC
- PMC3886380
- OpenAlex
- W2149341227
- Cited by
- 161
- References
- 69
- Citations by year
- 2026: 12 · 2025: 14 · 2024: 18 · 2023: 10 · 2022: 17 · 2021: 20 · 2020: 15 · 2019: 15 · 2018: 7 · 2017: 8 · 2016: 10 · 2015: 10 · 2014: 5
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Therapeutic Advances in Neurological Disorders (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- Parkinson's disease, anxiety, psychiatric comorbidity, benzodiazepines, bromazepam, selective serotonin reuptake inhibitors, multimodal therapy, quality of life, caregiver burden, fall risk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
